Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dirk Spitzer

6PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Jul 18, 2025
Trametinib Thwarts Activation of Survival Pathways Induced by Pro-ferroptotic Drug Conjugate ACXT-3102 Resulting in Enhanced Pancreatic Cancer Cell Death.

Kumar S Bishnupuri, Kenneth F Newcomer, Qingqing Gong

|Jul 03, 2025
Trametinib thwarts activation of survival pathways induced by pro-ferroptotic drug conjugate ACXT-3102 resulting in enhanced pancreatic cancer cell death.

Kumar S Bishnupuri, Kenneth F Newcomer, Qingqing Gong

|May 02, 2024
Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress.

Rony Takchi, Bethany C Prudner, Qingqing Gong

|Apr 14, 2022
Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102.

Caitlyn B Brashears, Bethany C Prudner, Richa Rathore

|Dec 22, 2017
Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer.

Lindsay M Kuroki, Xingjian Jin, Igor P Dmitriev

|Jan 19, 2017
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer.

Yassar M Hashim, Suwanna Vangveravong, Narendra V Sankpal

Pageof 1

Frequent Collaborators

4 joint publications

Brian A Van Tine

2 joint publications

Rony Takchi

2 joint publications

Lauren Ross

2 joint publications

Li Ye

2 joint publications

William G Hawkins

2 joint publications

Qingqing Gong

2 joint publications

Suwanna Vangveravong

2 joint publications

Kenneth F Newcomer

2 joint publications

Kumar S Bishnupuri

1 joint publications

Bethany C Prudner

Frequent Collaborators

4 joint publications

Brian A Van Tine

2 joint publications

Rony Takchi

2 joint publications

Lauren Ross

2 joint publications

Li Ye

Top Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

18.8K
Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries

Published on : Jan 22, 2019

9.1K
See more related videos

Top Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

18.8K
Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries

Published on : Jan 22, 2019

9.1K
See more related videos